| |
|
Company
Name |
Short
Summary |
| Achaogen |
Achaogen is focused on the research and development of antibiotics for the treatment of serious multi-drug resistant (MDR) Gram-negative bacterial infections. |
| Amgen |
Amgen
develops therapeutic proteins in oncology/hematopoiesis,
inflammation, and neurobiology/endocrinology. |
| BioSurplus |
BioSurplus is focused on providing equipment management solutions and pre-owned scientific instruments to the life sciences industry. |
| Catalyst Biosciences |
Catalyst Biosciences is focused on creating novel catalytic biopharmaceutical products based on engineered human proteases. |
| Cato
Research |
Cato Research is a global is
a full-service contract research and development
organization (CRO). |
| CoMentis |
CoMentis is focused on the development of two technology platforms: (i) aspartic protease inhibitors and (ii) nicotinic acetylcholine receptor (nAChR) agonists and antagonists for the treatment of angiogenesis mediated or cognitive disorders. |
| Cytokinetics |
Cytokinetics
is focused on the complementary missions of drug
discovery and the commercialization of novel cellular
bioinformatics technologies. |
| CytomX |
CytomX is focused on the research and development of monclonal antibody therapeutics. |
| DiaDexus |
DiaDexus
is a company formed as a joint venture between
SmithKline Beecham Corp. and Incyte Pharmaceuticals,
Inc., dedicated to the discovery and commercialization
of novel molecular diagnostics. |
| Exelixis |
Exelixis
is a rapidly growing, well-funded biopharmaceutical company whose mission is to
identify novel therapeutic targets for drug discovery
by elucidating the biochemical pathways involved
in human diseases. |
| Five Prime Therapeutics |
Five Prime Therapeutics is focused on the discovery, research, and development of protein and antibody drugs. |
| Fluidigm |
Fluidigm develops and distributes systems based on integrated fluidic circuits (IFCs). |
| Genentech |
Genentech,
Inc. is a leading biotechnology company using
human genetic information to develop, manufacture
and market biopharmaceuticals that address significant
unmet medical needs. |
| Iconic Therapeutics |
Iconic Therapeutics is focused on therapeutic use of I-con1™ protein for the “wet” form of adult macular degeneration and many cancers. |
| KaloBios Pharmaceuticals |
KaloBios is focused on the development of antibody therapeutics in autoimmunity, infectious disease, and cancer. |
| MacroGenics |
MacroGenics is focused on the development and commercialization of biologics for the treatment of autoimmune disorders, cancer and infectious diseases. |
| Monogram Biosciences |
Monogram Biosciences is focused on the research, development, and commercialization of molecular diagnostics for infectious diseases, cancer and other serious diseases. |
| NGM Biopharmaceuticals |
NGM Biopharmaceuticals is focused on the development of treatments for metabolic diseases, such as obesity, muscle wasting and cardiovascular disease in addition to diabetes. |
| Nodality |
Nodality is focused on utilizing advanced quantitative flow cytometry to enable clinical decision making for cancer treatment. |
| Onyx Pharmaceuticals |
Onyx Pharmaceuticals is focused on the research, development and commercialization of therapeutics for the treatment of cancer. |
| OXiGENE |
OXiGENE is focused on the discovery and development of therapeutics for patients with cancer and sight-threatening eye diseases and conditions. |
| Pfizer |
Pfizer Inc. is involved in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. |
| Pharmacyclics |
Pharmacyclics
is a pharmaceutical company developing energy-potentiating
drugs to improve radiation therapy and chemotherapy
of cancer, and to enable or improve the photodynamic
therapy of certain cancers and atherosclerotic
cardiovascular disease.
|
| Portola Pharmaceuticals |
Portola Pharmaceuticals is focused on developing therapeutics for the treatment of cardiovascular disease and inflammation. |
| Rigel |
Rigel
employs a set of unique technologies in the rapid
discovery and validation of novel pharmaceutical
targets, as well as in the design of therapeutic
agents which regulate the function of these targets
in specific disease processes. |
| Solazyme |
Solazyme is focused on the development and commercialization of oils and bioproducts dervied from microalgae. |
| Sunesis
Pharmaceuticals |
Sunesis
Pharmaceuticals is committed to becoming a leader
in the discovery of important new pharmaceutical
products for the treatment of human disease. They
are doing this by applying a revolutionary new
approach to drug discovery that is based on a
novel chemical methodology combined with critical
insights into the nature of molecular recognition
between natural macromolecules and their substrates
or ligands. |
| Sutro Biopharma |
Sutro Biopharma is focused on application of an Open Cell Free Synthesis (OCFS) technology which is an optimized E. coli extract for protein production. |
| Theravance |
Theravance is focused on small molecule drugs across a number of therapeutic areas with an initial focus on respiratory disease, bacterial infections and gastrointestinal disorders. |
| Threshold Pharmaceuticals |
Threshold Pharmaceuticals is focused on small molecule drugs that take advantage of tumor hypoxia. |
| Titan
Pharmaceuticals |
Titan
Pharmaceuticals develops products for the treatment
of cancer and central nervous system disorders. |
| Trellis Bioscience |
Trellis Bioscience is focused on monoclonal antibody therapeutics for infectious disease and oncology. |
